HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of varying the time interval between intratracheal administration of eglin-c and human neutrophil elastase on prevention of emphysema and secretory cell metaplasia in hamsters. With observations on the fate of eglin-c and the effect of repeated instillations.

Abstract
Eglin-c is a naturally occurring polypeptide of 70 amino acids with a molecular mass of 8,100 daltons. It is a strong inhibitor of human neutrophil elastase (HNE) and cathepsin-G, and, when given intratracheally to hamsters 1 h before human neutrophil elastase, it can prevent or ameliorate the emphysema produced by HNE. The present experiments were designed to determine the duration of the effectiveness of eglin-c, prepared by DNA technology from Escherichia coli, in preventing the emphysema and secretory cell metaplasia induced by HNE. Eglin-c (2,000 micrograms in 0.5 ml saline) was effective in ameliorating emphysema, as determined histologically and physiologically, when it was given intratracheally to hamsters 1, 2, 4, and 8 h before the intratracheal instillation of 300 micrograms of HNE. Eglin-c ameliorated bronchial secretory cell metaplasia when given 1 h before HNE but not when the time intervals were 2 h or longer. The clearance of [3H]eglin-c from the lungs was assessed. Four h after intratracheal instillation of 446 micrograms of [3H]eglin-c, 33% of the tritium was found in the lung tissue and bronchoalveolar lavage fluid; 83% of the radioactivity in the lavage fluid supernatant was associated with functionally active eglin-c. No evidence of bronchopulmonary toxicity was seen in hamsters given 4 intratracheal instillations of 2,000 micrograms of eglin-c at 1-wk intervals.
AuthorsE C Lucey, P J Stone, T G Christensen, R Breuer, J D Calore, G L Snider
JournalThe American review of respiratory disease (Am Rev Respir Dis) Vol. 134 Issue 3 Pg. 471-5 (Sep 1986) ISSN: 0003-0805 [Print] United States
PMID3530070 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Protease Inhibitors
  • Proteins
  • Serpins
  • eglin proteinase inhibitors
  • Pancreatic Elastase
Topics
  • Animals
  • Bronchi (drug effects, metabolism, pathology)
  • Cricetinae
  • Humans
  • Lung (metabolism, pathology)
  • Male
  • Mesocricetus
  • Metaplasia
  • Neutrophils (enzymology)
  • Pancreatic Elastase (toxicity)
  • Protease Inhibitors (administration & dosage)
  • Proteins (administration & dosage, metabolism, toxicity)
  • Pulmonary Emphysema (metabolism, pathology, prevention & control)
  • Serpins
  • Trachea

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: